Scynexis (SCYX) EPS (Weighted Average and Diluted) (2013 - 2026)
Scynexis (SCYX) reported EPS (Weighted Average and Diluted) of -$0.42 for Q1 2026, down 281.82% on a YoY basis from $0.23 in Q1 2025, and down 268.0% quarter-over-quarter from $0.25 in Q4 2025.
Scynexis (SCYX) EPS (Weighted Average and Diluted) (2013 - 2026) Analysis & Trends
Scynexis has reported EPS (Weighted Average and Diluted) for 14 years, with the latest figure at -$0.42 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 281.82% year-over-year to -$0.42; the trailing twelve-month figure through Mar 2026 stood at -$0.48 (up 14.29% YoY), and the FY2025 full-year result was -$0.17, up 61.36% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.42, down from $0.25 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $2.46 in Q2 2023, with the low at -$0.71 in Q1 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.07 across 5 years, with a median of -$0.17 in 2025.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) surged 893.55% — and 2025, when it tumbled 1200.0%.
- Scynexis' EPS (Weighted Average and Diluted) stood at -$0.29 in 2022, then slumped by 34.48% to -$0.39 in 2023, then soared by 76.92% to -$0.09 in 2024, then jumped by 377.78% to $0.25 in 2025, then tumbled by 268.0% to -$0.42 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.42 (Q1 2026), $0.25 (Q4 2025), and -$0.17 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | 0.25 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.11 |
| Dec 31, 2024 | -0.09 |
| Sep 30, 2024 | -0.06 |
| Jun 30, 2024 | -0.30 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | -0.39 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | 2.46 |
| Mar 31, 2023 | -0.71 |
| Dec 31, 2022 | -0.29 |
| Sep 30, 2022 | -0.62 |
| Jun 30, 2022 | -0.31 |
| Mar 31, 2022 | -0.18 |
| Dec 31, 2021 | -0.52 |
| Sep 30, 2021 | -0.06 |
| Jun 30, 2021 | -0.22 |